Max Hodak: The first people to live to a thousand years may already be alive, brain-computer interfaces will revolutionize healthcare, and ethical considerations are crucial for BCI deployment | Y Combinator Startup Podcast

Brain-computer interfaces could soon restore vision for the blind, revolutionizing human interaction with technology.

Listen on Y Combinator Startup Podcast

Share

Add us on Google by Editorial Team Mar. 25, 2026

Key takeaways

• Longevity research suggests that the first individuals to live for a thousand years may already be alive today.
• Brain-computer interfaces (BCIs) are expected to diversify, with multiple companies targeting different applications.
• BCI technology developed by Science can help blind patients regain sight by bypassing damaged retinal cells.
• BCIs will evolve similarly to pharmaceuticals, with various modalities tailored for different conditions.
• The risk-reward balance in deploying BCIs should prioritize the most disabled patients.
• The brain remains more plastic throughout life than commonly believed, allowing for learning and adaptation even in adulthood.
• Missing critical periods in early development can lead to irreversible neural issues.
• The brain’s plasticity allows it to adapt and learn from feedback, but this adaptability decreases over time.
• Blind patients often experience hallucinations due to the brain’s attempt to generate visual input without signals from the optic nerve.
• Vision restoration technology could achieve close to native acuity within the next ten years.
• BCIs are poised to revolutionize how we interact with technology and enhance human capabilities.
• Ethical considerations are crucial in the development and deployment of BCIs.
• Neuroplasticity plays a significant role in the potential success of brain-computer interfaces.
• Advancements in biotechnology are driving predictions about extended human longevity.
• The diversity of approaches in the BCI market highlights the technology’s potential impact across various applications.

Guest intro

Max Hodak is the founder and CEO of Science Corporation, a clinical-stage company developing brain-computer interfaces including a retinal implant to restore vision in blind patients. He is a co-founder and former president of Neuralink. Science has treated over 40 patients in clinical trials, with 80% showing improved visual acuity to read letters, numbers, and words.

The future of human longevity

• The first people to live to a thousand years old may already be alive today.

  — Max Hodak

• This prediction is based on current advancements in biotechnology and longevity research.
• The statement reflects a bold vision for the future of human life expectancy.
• Longevity research is rapidly evolving, with potential implications for healthcare and society.
• Understanding the science behind aging is crucial for extending human lifespan.
• Biotechnological advancements are key to unlocking the secrets of longevity.
• The possibility of living to a thousand years challenges current perceptions of aging.
• Ethical and societal considerations will play a significant role in the pursuit of extended longevity.

The evolving landscape of brain-computer interfaces

• Brain-computer interfaces (BCIs) will involve multiple companies targeting different applications with various types of probes.

  — Max Hodak

• BCIs are not a single product but a category with diverse applications.
• Different types of probes will be developed for specific BCI applications.
• The BCI market is expected to see significant growth and diversification.
• BCIs have the potential to revolutionize various industries, including healthcare.
• Understanding the BCI landscape is crucial for identifying future opportunities.
• Collaboration among companies will drive innovation in the BCI field.
• BCIs represent a convergence of technology and neuroscience.

Restoring sight with BCI technology

• The BCI technology developed by Science allows blind patients to regain sight by bypassing damaged retinal cells.

  — Max Hodak

• The technology uses a tiny array of solar panels to bypass dead rods and cones.
• This innovation provides a visual signal back into the retina, restoring sight.
• Over 40 patients have already benefited from this groundbreaking retinal implant.
• The technology showcases the potential impact of BCIs on vision restoration.
• Understanding retinal diseases is crucial for advancing this technology.
• The success of this technology highlights the promise of BCIs in healthcare.
• BCIs are poised to transform the lives of visually impaired individuals.

BCIs as a new category in medicine

• Brain-computer interfaces (BCIs) will have various modalities tailored for different conditions, similar to pharmaceuticals.

  — Max Hodak

• BCIs will be categorized like pharmaceuticals, with specific applications for different conditions.
• The development of BCIs will require collaboration across multiple disciplines.
• Tailored BCI solutions will address specific medical needs and conditions.
• The potential applications of BCIs in medicine are vast and varied.
• Understanding the medical landscape is crucial for successful BCI deployment.
• BCIs represent a new frontier in personalized medicine.
• Ethical considerations will guide the development of BCIs in healthcare.

Ethical considerations in BCI deployment

• The risk-reward balance in deploying BCIs should prioritize the most disabled patients who stand to gain the most from basic functionality.

  — Max Hodak

• Prioritizing the most disabled patients ensures ethical deployment of BCIs.
• The risk-reward balance is crucial for responsible innovation in BCIs.
• Ethical frameworks will guide the development and deployment of BCIs.
• Understanding the ethical implications is essential for BCI advancement.
• BCIs have the potential to significantly improve the quality of life for disabled individuals.
• Collaboration with ethicists will be crucial for navigating ethical challenges in BCI development.
• Prioritizing patient needs will drive ethical innovation in BCIs.

Neuroplasticity and its implications for BCIs

• The brain remains more plastic throughout life than commonly believed, allowing for learning and adaptation even in adulthood.

  — Max Hodak

• Neuroplasticity plays a significant role in the potential success of BCIs.
• Understanding neuroplasticity is crucial for advancing BCI technology.
• The brain’s ability to adapt and learn is key to successful BCI integration.
• Neuroplasticity challenges traditional perceptions of brain function and learning.
• BCIs can leverage neuroplasticity to enhance human capabilities.
• The adaptability of the brain offers new opportunities for BCI innovation.
• Understanding the science of neuroplasticity is essential for BCI development.

Critical periods in neural development

• There are critical periods in early development for certain neural functions, and missing these can lead to irreversible issues.

  — Max Hodak

• Early neural development is crucial for optimal brain function.
• Missing critical periods can result in long-term neural challenges.
• Understanding developmental neuroscience is essential for BCI advancement.
• The importance of early neural development highlights the potential of BCIs.
• BCIs can potentially address challenges resulting from missed critical periods.
• Collaboration with developmental neuroscientists will drive BCI innovation.
• Understanding the limitations of neurotechnology is crucial for responsible BCI development.

The brain’s plasticity and learning

• The brain’s plasticity allows it to adapt and learn from feedback, but this adaptability decreases as it stabilizes in response to reality.

  — Max Hodak

• The brain’s plasticity is a key factor in learning and adaptation.
• Understanding brain plasticity is crucial for advancing BCI technology.
• The adaptability of the brain offers new opportunities for BCI innovation.
• BCIs can leverage the brain’s plasticity to enhance human capabilities.
• Understanding the science of brain plasticity is essential for BCI development.
• The brain’s ability to adapt and learn is key to successful BCI integration.
• Neuroplasticity challenges traditional perceptions of brain function and learning.

Sensory perception in blind patients

• Blind patients experience hallucinations due to the brain’s attempt to generate visual input when it doesn’t receive signals from the optic nerve.

  — Max Hodak

• Understanding sensory perception is crucial for advancing vision restoration technologies.
• The brain’s attempt to generate visual input highlights its adaptability.
• BCIs can potentially address sensory perception challenges in blind patients.
• Understanding the relationship between sensory input and brain perception is essential for BCI development.
• The adaptability of the brain offers new opportunities for BCI innovation.
• Collaboration with neuroscientists will drive advancements in vision restoration technologies.
• Understanding the complexities of sensory perception is crucial for BCI success.

Vision restoration technology advancements

• In the next ten years, we could achieve close to native acuity in vision restoration technology.

  — Max Hodak

• Advancements in BCI technology are driving predictions for improved vision restoration.
• The potential for achieving native acuity highlights the promise of BCIs in healthcare.
• Understanding current limitations is crucial for advancing vision restoration technologies.
• Collaboration with experts will drive innovation in vision restoration technology.
• The success of vision restoration technologies showcases the potential impact of BCIs.
• Understanding the science behind vision restoration is essential for BCI development.
• BCIs are poised to transform the lives of visually impaired individuals.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.